Bonito N - Search Results

1

Dionísio de Sousa IJ, Bonito N, Pais A, Gervásio H. Dionísio de Sousa IJ, et al. Among authors: bonito n. BMJ Case Rep. 2016 Mar 8;2016:bcr2016214496. doi: 10.1136/bcr-2016-214496. BMJ Case Rep. 2016. PMID: 26957036 Free PMC article.

2

Primary non-Hodgkin lymphoma and invasive ductal carcinoma in the same breast: a rare case report.

Broco S, Bonito N, Jacinto P, Sousa G, Gervásio H. Broco S, et al. Among authors: bonito n. Clin Transl Oncol. 2009 Mar;11(3):186-8. doi: 10.1007/s12094-009-0337-7. Clin Transl Oncol. 2009. PMID: 19293058

3

Association between bevacizumab-related hypertension and response to treatment in patients with metastatic colorectal cancer.

Dionísio de Sousa IJ, Ferreira J, Rodrigues J, Bonito N, Jacinto P, Marques M, Ribeiro J, Pais A, Gervásio H. Dionísio de Sousa IJ, et al. Among authors: bonito n. ESMO Open. 2016 May 17;1(3):e000045. doi: 10.1136/esmoopen-2016-000045. eCollection 2016. ESMO Open. 2016. PMID: 27843607 Free PMC article.

4

Bone Metastases: An Overview.

Macedo F, Ladeira K, Pinho F, Saraiva N, Bonito N, Pinto L, Goncalves F. Macedo F, et al. Among authors: bonito n. Oncol Rev. 2017 May 9;11(1):321. doi: 10.4081/oncol.2017.321. eCollection 2017 Mar 3. Oncol Rev. 2017. PMID: 28584570 Free PMC article. Review.

5

Current opinion about antimicrobial therapy in palliative care: an update.

Macedo F, Bonito N. Macedo F, et al. Among authors: bonito n. Curr Opin Oncol. 2019 Jul;31(4):299-301. doi: 10.1097/CCO.0000000000000514. Curr Opin Oncol. 2019. PMID: 30747735 Review.

6

The effect of prognostic factors at baseline on the efficacy of trifluridine/tipiracil in patients with metastatic colorectal cancer: A Portuguese exploratory analysis.

Sousa MJ, Gomes I, Pereira TC, Magalhães J, Basto R, Paulo J, Jacinto P, Bonito N, Sousa G. Sousa MJ, et al. Among authors: bonito n. Cancer Treat Res Commun. 2022;31:100531. doi: 10.1016/j.ctarc.2022.100531. Epub 2022 Feb 9. Cancer Treat Res Commun. 2022. PMID: 35172243 Free article.

7

A prospective cohort study of TIMP1 as prognostic biomarker in gastric and colon cancer.

Macedo FC, Cunha N, Pereira TC, Soares RF, Monteiro AR, Bonito N, Valido F, Sousa G. Macedo FC, et al. Among authors: bonito n. Chin Clin Oncol. 2022 Dec;11(6):43. doi: 10.21037/cco-22-69. Epub 2022 Nov 22. Chin Clin Oncol. 2022. PMID: 36509552 Free article.

8

Antimicrobial therapy in palliative care: an overview.

Macedo F, Nunes C, Ladeira K, Pinho F, Saraiva N, Bonito N, Pinto L, Gonçalves F. Macedo F, et al. Among authors: bonito n. Support Care Cancer. 2018 May;26(5):1361-1367. doi: 10.1007/s00520-018-4090-8. Epub 2018 Feb 12. Support Care Cancer. 2018. PMID: 29435712 Review.

9

Therapeutic impact of determination of RAS mutations in the plasma of patient with colorectal cancer.

Macedo F, Monteiro J, Pereira TC, Monteiro AR, Felix Soares R, Bonito N, Sousa G. Macedo F, et al. Among authors: bonito n. Gastroenterol Hepatol Bed Bench. 2022 Winter;15(1):93-98. Gastroenterol Hepatol Bed Bench. 2022. PMID: 35611253 Free PMC article.

10

Metastatic lymph node ratio as a better prognostic tool than the TNM system in colorectal cancer.

Macedo F, Sequeira H, Ladeira K, Bonito N, Viana C, Martins S. Macedo F, et al. Among authors: bonito n. Future Oncol. 2021 Apr;17(12):1519-1532. doi: 10.2217/fon-2020-0993. Epub 2021 Feb 25. Future Oncol. 2021. PMID: 33626938

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page